Select Page

3 Q&A Interview with CEO, Kent M. Payne, new MVA-member, BioDuro-Sundia

May 2, 2023

Q1: Why has BioDuro-Sundia decided to join Medicon Valley Alliance?

BioDuro-Sundia is a global Contract Research, Development, and Manufacturing Organization (CRDMO), with offerings from target identification to drug product manufacturing at commercial scale. Medicon Valley is one of the largest life science hubs in Europe. By joining Medicon Valley Alliance, BioDuro-Sundia contribute to the broader network and expertise, driving innovation and growth for our clients. We look forward to working alongside our fellow members.

Q2: What are the unique features of BioDuro-Sundia as a CRDMO?

With integrated solutions from Discovery, through Drug Substance to Drug Product, our established capabilities can save time by accelerating new drug R&D timelines.

BioDuro-Sundia started to work on PROTAC molecules in 2015, having collaborated extensively with MNC, Biotech/Biopharma, startups and academic institutions around the world. We have synthesized and scaled-up (to grams quantity) 1000+ PROTAC molecules, with deep expertise in PROTAC chemistry, including linkers and E3 ligase binder design and synthesis. We have also established a comprehensive biology evaluation platform for mechanistic studies of PROTAC/TPD with more than 30 assays to investigate all cellular events associated with PROTAC/TPD. We have strong expertise in building de novo HiBiT cell lines (> 40 HiBiT and NanoLuc cell lines built internally).

Our legacy as a pioneer in amorphous solid dispersion (ASD) development extends more than 27 years enhancing bioavailability of oral solid dosage forms. Our team of experts are dedicated to delivering high-quality results that meet the strict regulatory compliance in the industry. Our state-of-the-art facilities are equipped with the latest technologies and techniques, ensuring that we are always at the forefront of advancements in the field. We are a lean organization, and save time and cost for our clients bringing life-saving drug products faster to patients.

Q3: What are your first impression of Medicon Valley and the Nordics as an area of operation?

Medicon Valley is committed to enable innovative and effective solutions that benefit human health and society, and BioDuro-Sundia is committed to collaborating with pharma and biotech companies to accelerate life-saving medicines for millions of patients worldwide. Our shared values unite us, and we believe that working together will strengthen our ability to provide solutions for our clients.

3 Q&A interviews